Alibaba Health Information Technology Limited (HKG:0241)
6.04
+0.28 (4.86%)
Feb 21, 2025, 4:08 PM HKT
HKG:0241 Revenue
Alibaba Health Information Technology had revenue of 14.27B CNY in the half year ending September 30, 2024, with 24.11% growth. This brings the company's revenue in the last twelve months to 28.34B, up 0.45% year-over-year. In the fiscal year ending March 31, 2024, Alibaba Health Information Technology had annual revenue of 27.03B with 0.98% growth.
Revenue (ttm)
28.34B CNY
Revenue Growth
+0.45%
P/S Ratio
2.95
Revenue / Employee
19.75M CNY
Employees
1,435
Market Cap
97.13B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 27.03B | 263.54M | 0.98% |
Mar 31, 2023 | 26.76B | 6.19B | 30.06% |
Mar 31, 2022 | 20.58B | 5.06B | 32.60% |
Mar 31, 2021 | 15.52B | 5.92B | 61.71% |
Mar 31, 2020 | 9.60B | 4.50B | 88.32% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 26.04B |
JD Health International | 58.84B |
Hansoh Pharmaceutical Group Company | 13.00B |
WuXi Biologics | 18.39B |
Innovent Biologics | 8.01B |
Akeso | 2.01B |
Sinopharm Group | 634.32B |
Sino Biopharmaceutical | 29.86B |